Diagnostics News and Research

RSS

Study shows AI systems can accurately identify and grade prostate cancer

Researchers at Karolinska Institutet in Sweden have together with international collaborators completed a comprehensive international validation of artificial intelligence (AI) for diagnosing and grading prostate cancer.

13 Jan 2022

Ultra-rapid genome sequencing technology can detect rare genetic diseases in eight hours

A new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic diseases in an average of eight hours - a feat that's nearly unheard of in standard clinical care.

13 Jan 2022

The Native Antigen Company Expands Range of Norovirus-Like Particles

The Native Antigen Company today announced the expansion of its norovirus-like particle range, with the addition of six new reagents.

From The Native Antigen Company 13 Jan 2022

New type of blood test can be used to detect cancers as well as metastatic disease

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.

12 Jan 2022

Bruker introduces fast BioAFM for automated mechanobiology

Bruker today announced the release of the JPK NanoWizard® V BioAFM, a novel system that marks a milestone in automation and ease of use for life science atomic force microscopy research.

From Bruker BioAFM 12 Jan 2022

New method for monitoring circulating SARS-CoV-2 variants and detecting new ones

To understand and act early and appropriately to emerging variants of concern, researchers have explored the possibility of having a variant-agnostic detection assay.

12 Jan 2022

Development and validation of 2-gene host-based COVID-19 diagnostic classifiers

A group of researchers from Biohub has been attempting to create a more accurate method for PCR testing.

11 Jan 2022

Modeling shows that free SARS-CoV-2 rapid antigen tests for all Australians would benefit the economy

Researchers conducted a cost-effectiveness analysis of government-funded COVID-19 rapid antigen tests in Australia.

10 Jan 2022

Unique combination of nanomaterials in DNA biosensor enables easier SARS-CoV-2 detection

A recent paper that was published in the Talanta journal dedicated to original reports in pure and applied analytical chemistry presents for the first time the combination of two different nanomaterials – gold nanomaterials (AuNMs) and CDs for the development of an improved electrochemiluminescence (ECL) DNA biosensor.

10 Jan 2022

Researchers develop new biopsy technology for profiling multiple tumor microenvironment biomarkers

A team led by University of California, Irvine researchers has developed a new biopsy technology that can profile multiple tumor microenvironment biomarkers simultaneously, revealing cellular spatial organization and interactions that will help advance personalized disease diagnosis and treatment.

10 Jan 2022

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

A new study, published in Nature Communications and led by Imperial College London researchers, provides the first evidence of a protective role for these T cells.

10 Jan 2022

Common member of the gut microbiome found to have specific preference for blood group A antigens

Researchers have discovered that a common member of the human gut microbiome has a specific preference for blood group A antigens.

10 Jan 2022

New lab-on-a-chip platform for detecting SARS-CoV-2 in resource-limited settings

A recent study shows how a novel and integrated lab-on-a-chip platform can represent a rapid, affordable, and exact molecular diagnostic tool for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The paper is currently available for free on the medRxiv* preprint server while it undergoes peer review.

9 Jan 2022

NEJM article distills available data into a compendium about rapid diagnostic tests for COVID-19

A clinical practice article in the New England Journal of Medicine distills available data and clinical experience into a compendium about rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19.

7 Jan 2022

From laboratory to clinic - Nanotechnology-enabled mRNA COVID-19 vaccines

In a recently published article in the journal Nano-Micro Letters, scientists have provided an in-depth review on the application and benefits of nanotechnology in the development of coronavirus disease 2019 (COVID-19) vaccines.

7 Jan 2022

New drug targeting LF and onchocerciasis begins its first in human trial in Liverpool

A new drug developed by an LSTM led partnership, which targets the neglected tropical diseases lymphatic filariasis and onchocerciasis has begun its first in human trial.

6 Jan 2022

Siemens Healthineers Announces FDA Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test

The CLINITEST Rapid COVID-19 Antigen Self-Test has received FDA EUA for unsupervised self-testing for the SARS-CoV-2 virus by individuals age 14 and older (or adult-collected samples from individuals ages 2-13).

From Siemens Healthineers 4 Jan 2022

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening.

3 Jan 2022

WHO lists the Comirnaty COVID-19 mRNA vaccine for emergency use

The World Health Organization today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago.

2 Jan 2022

New test-to-stay approach enables kids and staffs to stay in school after COVID exposures

Children and staff who repeatedly test negative for COVID-19 after contact with someone who has the illness can safely remain in school if universal masking programs are in place, according to a new "test-to-stay" study report from the ABC Science Collaborative.

30 Dec 2021

Diagnostics News and Research

Study shows AI systems can accurately identify and grade prostate cancer

Ultra-rapid genome sequencing technology can detect rare genetic diseases in eight hours

The Native Antigen Company Expands Range of Norovirus-Like Particles

New type of blood test can be used to detect cancers as well as metastatic disease

Bruker introduces fast BioAFM for automated mechanobiology

New method for monitoring circulating SARS-CoV-2 variants and detecting new ones

Development and validation of 2-gene host-based COVID-19 diagnostic classifiers

Modeling shows that free SARS-CoV-2 rapid antigen tests for all Australians would benefit the economy

Unique combination of nanomaterials in DNA biosensor enables easier SARS-CoV-2 detection

Researchers develop new biopsy technology for profiling multiple tumor microenvironment biomarkers

T cells induced by common cold coronaviruses play a protective role against COVID-19 infection

Common member of the gut microbiome found to have specific preference for blood group A antigens

New lab-on-a-chip platform for detecting SARS-CoV-2 in resource-limited settings

NEJM article distills available data into a compendium about rapid diagnostic tests for COVID-19

From laboratory to clinic - Nanotechnology-enabled mRNA COVID-19 vaccines

New drug targeting LF and onchocerciasis begins its first in human trial in Liverpool

Siemens Healthineers Announces FDA Emergency Use Authorization for CLINITEST® Rapid COVID-19 Antigen Self-Test

COVID-19 tests with the new assay may be just as reliable as laboratory-based molecular tests

WHO lists the Comirnaty COVID-19 mRNA vaccine for emergency use

New test-to-stay approach enables kids and staffs to stay in school after COVID exposures

Event guide: 16th Clinical Biomarkers & CDx Summit Europe eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News